Birchview Capital, LP Aveo Pharmaceuticals, Inc. Transaction History

Birchview Capital, LP

  • $108 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 03, 2023
SELL
$8.48 - $14.97 $339,200 - $598,800
-40,000 Reduced 28.57%
100,000 $1.5 Million
Q4 2021

Feb 14, 2022
BUY
$4.69 - $7.4 $469,000 - $740,000
100,000 Added 250.0%
140,000 $657,000
Q3 2021

Nov 12, 2021
BUY
$5.12 - $6.89 $204,800 - $275,600
40,000 New
40,000 $247,000

Others Institutions Holding AVEO

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About AVEO PHARMACEUTICALS, INC.

AVEO Quotes by TradingView
  • Ticker AVEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,676,000
  • Description
  • AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the ...
More about AVEO
Track This Portfolio

Track Birchview Capital, LP Portfolio

Follow Birchview Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Birchview Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Birchview Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email